A phase I/II trial of concurrent chemo-radiation with dose-escalated radiotherapy in patients with stage II or stage III non-small cell lung cancer
Κύριοι συγγραφείς: | Landau, D, Miles, E, Illsley, M, Laurence, V, Hughes, S, Ngai, Y, Hughes, L, Khan, I, Mayles, H, Mayles, P, Fenwick, J |
---|---|
Μορφή: | Journal article |
Έκδοση: |
2013
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.
ανά: Panettieri, V, κ.ά.
Έκδοση: (2010) -
Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.
ανά: Fenwick, J, κ.ά.
Έκδοση: (2009) -
Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.
ανά: Warren, S, κ.ά.
Έκδοση: (2014) -
Early mucosal reactions during and after head-and-neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration.
ανά: Fenwick, J, κ.ά.
Έκδοση: (2008) -
UK proposal for three parallel dose escalation studies in radiotherapy (RT) for Stage I-III non-small cell lung cancer (NSCLQC)-DEAL-RT
ανά: Hughes, S, κ.ά.
Έκδοση: (2007)